Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1

Status

Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Prostatic Neoplasms 5Carcinoma, Hepatocellular 4Parathyroid Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Liver Diseases 1Hyperparathyroidism, Primary 1Disease 1Breast Neoplasms 1

Interventions

Sorafenib 202lenvatinib 129Bevacizumab 124Nivolumab 85pembrolizumab 72atezolizumab 72Radiosurgery 71durvalumab 63Oxaliplatin 59sintilimab 57Fluorouracil 54Doxorubicin 44tislelizumab 43apatinib 43Leucovorin 40tremelimumab 37camrelizumab 37Radiofrequency Ablation 37Radiotherapy 36Magnetic Resonance Spectroscopy 32Capecitabine 30regorafenib 29Folfox protocol 29Cisplatin 28cabozantinib 26Hepatectomy 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25toripalimab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Hepatocellular × fluorocholine × Clear all
NCT04965454 2025-05-01

ExTRACT-HCC

Queen's Medical Center

Phase 2 Recruiting
80 enrolled
Gastrointestinal

Disease, Carcinoma, Hepatocellular

NCT04391348 2023-11-18

PET-HCC01

Assistance Publique - Hôpitaux de Paris

Phase NA Completed
230 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01395030 2018-09-26

PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection

Queen's Medical Center

Phase 2 Completed
64 enrolled 13 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT02074202 2014-02-28

To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma

National Taiwan University Hospital

Phase 3 Unknown
150 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡